Innovations in breast oncology can translate to improved patient outcomes for patients with early and late-stage disease. In this webinar, Dr. Ray will discuss the latest research findings and how they can be translated into the clinical care of patients with breast cancer.

Brian Colwell Jensen, MD, will introduce the audience to potential cardiovascular adverse effects of contemporary cancer therapeutics.

Natalie Grover, MD, will review some of the recent advances in the treatment of lymphoma, including the incorporation of novel targeted agents in the frontline treatment of diffuse large B cell lymphoma and Hodgkin lymphoma, the use of CAR-T cell therapy in second-line treatment in diffuse large B cell lymphoma, and recently approved drugs by the FDA for lymphoma.

In working to address Native American cancer health disparities, it is imperative to build partnerships with tribal communities to increase their trust in the potential benefits of cancer research efforts. The Partnership for Native American Cancer Prevention was established in 2002 and the Partnership’s approach is to expand capacity for culturally-sensitive and community-relevant research on cancer and to continue to develop respectful collaborations that empower sovereign Native American communities to define, implement, and achieve their goals for cancer health equity.